16 research outputs found

    Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment

    Get PDF
    In an unbiased approach to biomarker discovery, we applied a highly multiplexed proteomic technology (SOMAscan, SomaLogic, Inc, Boulder, CO) to understand changes in proteins from paired serum samples at enrollment and after 8 weeks of TB treatment from 3

    Unpaired analysis of proteins showing differential expression between baseline and week 8 in <i>n</i>ā€Š=ā€Š39 TB patients.

    No full text
    <p>A total of 60 proteins were differentially expressed using the KS test and 0.01% false discovery rate (q <10<sup>āˆ’4</sup>; for all 116 proteins with q <10<sup>āˆ’3</sup> see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0061002#pone.0061002.s007" target="_blank">Table S4</a>). The shift in expression is shown as the signed KS-distance, with a positive KS value indicating up-regulation of the protein after 8 weeks of TB therapy. Also shown are the raw p-value and resulting FDR corrected ā€œq-valueā€.</p>*<p>Swiss Prot is a large protein sequence database widely used for protein resources.</p
    corecore